Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence

Mostrar otras versiones (1)

Novel immunotherapy combination therapies have improved outcomes for patients with hepatocellular carcinoma (HCC), but responses are limited to a subset of patients and recurrence can also occur. Little is known about the inter- and intra-tumor heterogeneity in cellular signaling networks within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuming, Yuan, Long, Danilova, Ludmila, Mo, Guanglan, Zhu, Qingfeng, Deshpande, Atul, Bell, Alexander T.F., Elisseeff, Jennifer, Popel, Aleksander S., Anders, Robert A., Jaffee, Elizabeth M., Yarchoan, Mark, Fertig, Elana J., Kagohara, Luciane T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882076/
https://www.ncbi.nlm.nih.gov/pubmed/36712023
http://dx.doi.org/10.1101/2023.01.10.523481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882076/
https://www.ncbi.nlm.nih.gov/pubmed/36712023
http://dx.doi.org/10.1101/2023.01.10.523481

Ejemplares similares